Story perspectives
GLP-1 Drugs Show Promise in Cancer Treatment Amid Job Cuts
9/12/2025
1 of 1
Story summary
- GLP-1 drugs like Ozempic and Wegovy may aid cancer treatment by targeting risk factors and enhancing immune response.
- Deborah Phippard notes their potential to lower cancer risks associated with obesity and diabetes.
- Early studies indicate GLP-1s might help combat chemotherapy resistance.
- Concerns about side effects, including muscle loss and potential cancer links, persist.
- Novo Nordisk plans to cut 9,000 jobs due to declining stock and competition.
